16TH CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD)

The Clinical Trials on Alzheimer’s Disease conference (CTAD) is a meeting focused entirely on Alzheimer’s Disease Therapeutic Trials with key leaders in Alzheimer Disease research from Industry and Academia getting together and forming partnerships with the objective of speeding the development of effective treatments to fight the disease.

The 16th annual CTAD conference will be held in Boston on October 24 – 27, 2023.  

CTAD is the only event dedicated entirely to Alzheimer’s disease therapeutic trials.
Join experts from academia and industry presenting their data on Alzheimer’s disease diagnosis and therapy.

The call for communication will open soon.

Scientific program

The scientific program is not yet available.

Registration CTAD23

The registrations will open soon.